Arthur Juban
About Arthur Juban
Arthur Juban is an Apprenti Médico-Economie & Santé Publique at Bristol Myers Squibb in Paris, with a diverse background in pharmaceutical and health economics roles across various institutions.
Current Role at Bristol Myers Squibb
Arthur Juban is currently serving as an Apprenti Médico-Economie & Santé Publique - HEOR at Bristol Myers Squibb in Ville de Paris, Île-de-France, France. In this role, he contributes to the development of health economic models, leveraging his expertise to support decision-making processes within the company.
Previous Experience at Haute Autorité de Santé
Arthur Juban worked as an Assistant Project Manager (Assistant chef de projet) in the Service Evaluation des Medicaments at Haute Autorité de Santé in 2021 for 5 months. During his time there, he assisted in the evaluation of medications, gaining valuable experience in healthcare evaluation and regulatory processes.
Educational Background in Health Economics
Arthur Juban holds a Master 2 (M2) in Evaluation Médico-Economique et Accès au Marché from Paris-Dauphine, completed between 2021 and 2022. Additionally, he studied at EHESP - École des hautes études en santé publique, achieving UE - Analyse médico-économique in 2021 for 11 months. These qualifications reflect his strong foundation in medical economics and public health.
Professional Experience at CHU de Rennes
Arthur Juban has extensive hands-on experience from his time at CHU de Rennes. He worked in clinical pharmacology trials (Extern en pharmacie - Pharmacologie clinique) from 2020 to 2021 for 3 months. He also gained experience in emergency medical services (Extern en pharmacie - SAMU-SMUR-Urgences) in 2020 for 2 months. These roles provided him with practical insights into pharmacological research and emergency healthcare services.
Leadership Role at CapIndus
Arthur Juban held the position of Vice President at CapIndus from 2019 to 2021. During his tenure, he oversaw various initiatives and projects, demonstrating his leadership capabilities and active involvement in the organization. He was also an active member of the organization from 2017 to 2019, contributing to its development and success.